Search Result "TRAIL."


Targeting Trail Towards the Clinic

Journal: Current Drug Targets
Volume: 12 Issue: 1 Year: 2011 Page: 2079-2090
Author(s): Devalingam Mahalingam, Corina N.A.M. Oldenhuis, Eva Szegezdi, Francis J. Giles, Elisabeth G.E. de Vries, Steven de Jong, Steffan T. Nawrocki

APO2L/TRAIL: New Insights in the Treatment of Autoimmune Disorders

Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 5 Issue: 3 Year: 2011 Page: 184-199
Author(s): Alberto Anel, Luis Martinez-Lostao

Regulating TRAIL Receptor-Induced Cell Death at the Membrane: A Deadly Discussion

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 6 Issue: 3 Year: 2011 Page: 311-323
Author(s): Sarah Shirley, Alexandre Morizot, Olivier Micheau

Therapeutic Targeting of CD95 and the TRAIL Death Receptors

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 6 Issue: 3 Year: 2011 Page: 294-310
Author(s): Jeannette Gerspach, Klaus Pfizenmaier, Harald Wajant

Doxorubicin Sensitizes the Non-Small Cell Lung Cancer Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated (TRAIL) Apoptosis In Vitro but not In Vivo

Journal: Letters in Drug Design & Discovery
Volume: 8 Issue: 9 Year: 2011 Page: 861-867
Author(s): Li Fan, Liangran Guo, Jinfeng Ren, Yulong Ren, Zhiqing Pang, Xinguo Jiang

Review on Development and Recent Patents on Trailing Vortices Alleviation

Journal: Recent Patents on Mechanical Engineering
Volume: 4 Issue: 2 Year: 2011 Page: 83-129
Author(s): Harijono Djojodihardjo

Targeting Cell Death and Survival Receptors in Hepatocellular Carcinoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11 Issue: 6 Year: 2011 Page: 576-584
Author(s): Jordi Muntane

Regulation of Death and Growth Signals at the Plasma Membrane by Sphingomyelin Synthesis: Implications for Hematological Malignancies

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 6 Issue: 3 Year: 2011 Page: 324-333
Author(s): Elodie Lafont, Kazuyuki Kitatani, Toshiro Okazaki, Bruno Segui

Recent Advances in the Therapeutic Perspectives of Nutlin-3

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 6 Year: 2011 Page: 569-577
Author(s): Paola Secchiero, Raffaella Bosco, Claudio Celeghini, Giorgio Zauli

Bortezomib Targets the Caspase-Like Proteasome Activity in Cervical Cancer Cells, Triggering Apoptosis That Can be Enhanced by Nelfinavir

Journal: Current Cancer Drug Targets
Volume: 11 Issue: 7 Year: 2011 Page: 799-809
Author(s): A. Bruning, M. Vogel, I. Mylonas, K. Friese, A. Burges

Previous   Next

Go To   Results 1 - 1 of 283

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy